Minor
Redefine · COMP360 · Post-traumatic Stress Disorder
Trial sites expanded: 4 → 8 locations
COMPASS PathwaysPhase 2/3 NCT07570654 Registry history of NCT07570654 on ClinicalTrials.gov (opens the registry)
Updated
3 active trials 1 recruiting 2 Phase 3 2 disease areas 1 changes in 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 4 → 8 locations
COMPASS PathwaysPhase 2/3 NCT07570654 Registry history of NCT07570654 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 2 | 1 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05711940 | Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With… | Treatment Resistant Depression | Active, Not Recruiting | 2026-08-10 |
| Phase 2/3 | ||||
| NCT07570654 | Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in… | PTSD - Post Traumatic Stress Disorder | Recruiting | 2026-10-06 |
| Phase 2 | ||||
| NCT05733546 | A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the… | Major Depressive Disorder | Active, Not Recruiting | 2025-08-19 |
Depression (2) · PTSD (1)